201 related articles for article (PubMed ID: 31622424)
1. Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study.
Kim BK; Kim DY; Han KH; Seong J
PLoS One; 2019; 14(10):e0223678. PubMed ID: 31622424
[TBL] [Abstract][Full Text] [Related]
2. The management and prognosis of patients with hepatocellular carcinoma: what has changed in 20 years?
Yim SY; Seo YS; Jung CH; Kim TH; Lee JM; Kim ES; Keum B; Jong YK; An H; Kim JH; Yim HJ; Kim DS; Jeen YT; Yeon JE; Lee HS; Chun HJ; Byun KS; Um SH; Kim CD; Ryu HS
Liver Int; 2016 Mar; 36(3):445-53. PubMed ID: 26352789
[TBL] [Abstract][Full Text] [Related]
3. Effective therapeutic options for elderly patients with hepatocellular carcinoma: A nationwide cohort study.
Shin J; Yu JH; Jin YJ; Suh YJ; Kim DH; Byun S; Lee JW
Medicine (Baltimore); 2019 Jul; 98(30):e16150. PubMed ID: 31348228
[TBL] [Abstract][Full Text] [Related]
4. Trend of improving prognosis of hepatocellular carcinoma in clinical practice: an Italian in-field experience.
Borzio M; Dionigi E; Rossini A; Toldi A; Francica G; Fornari F; Salmi A; Farinati F; Vicari S; Marignani M; Terracciano F; Ginanni B; Sacco R
Dig Dis Sci; 2015 May; 60(5):1465-73. PubMed ID: 25399329
[TBL] [Abstract][Full Text] [Related]
5. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
[TBL] [Abstract][Full Text] [Related]
6. BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group.
Farinati F; Vanin V; Giacomin A; Pozzan C; Cillo U; Vitale A; Di Nolfo AM; Del Poggio P; Benvegnu' L; Rapaccini G; Zoli M; Borzio F; Giannini EG; Caturelli E; Trevisani F;
Liver Int; 2015 Jan; 35(1):223-31. PubMed ID: 25074434
[TBL] [Abstract][Full Text] [Related]
7. Treatment allocation in hepatocellular carcinoma: Assessment of the BCLC algorithm.
Richani M; Kolly P; Knoepfli M; Herrmann E; Zweifel M; von Tengg-Kobligk H; Candinas D; Dufour JF
Ann Hepatol; 2016; 15(1):82-90. PubMed ID: 26626644
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases.
Fenoglio L; Serraino C; Castagna E; Cardellicchio A; Pomero F; Grosso M; Senore C
World J Gastroenterol; 2013 Jun; 19(21):3207-16. PubMed ID: 23745022
[TBL] [Abstract][Full Text] [Related]
9. Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis.
Piñero F; Marciano S; Fernández N; Silva J; Anders M; Zerega A; Ridruejo E; Romero G; Ameigeiras B; D'Amico C; Gaite L; Bermúdez C; Reggiardo V; Colombato L; Gadano A; Silva M
World J Gastroenterol; 2019 Jul; 25(27):3607-3618. PubMed ID: 31367160
[TBL] [Abstract][Full Text] [Related]
10. Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma.
Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Park MS; Kim EH; Seong J; Lee DY; Han KH
Liver Int; 2012 Aug; 32(7):1120-7. PubMed ID: 22524688
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic priorities for solitary large hepatocellular carcinoma in a hepatitis B virus endemic area; an analysis of a nationwide cancer registry database.
Jin YJ; Lee JW
J Surg Oncol; 2017 Mar; 115(4):407-416. PubMed ID: 28008620
[TBL] [Abstract][Full Text] [Related]
12. Improvement of clinical management and outcome in hepatocellular carcinoma nowadays compared with historical cohorts.
Schellhaas B; Strobel D; Stumpf M; Ganslmayer M; Pfeifer L; Goertz RS; Neurath MF; Zopf S
Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1422-1427. PubMed ID: 30052538
[TBL] [Abstract][Full Text] [Related]
13. Treatment of hepatocellular carcinoma in a tertiary Romanian center. Deviations from BCLC recommendations and influence on survival rate.
Radu P; Groza I; Iancu C; Al Hajjar N; Andreica V; Sparchez Z
J Gastrointestin Liver Dis; 2013 Sep; 22(3):291-7. PubMed ID: 24078986
[TBL] [Abstract][Full Text] [Related]
14. The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?
Kim KM; Sinn DH; Jung SH; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Liver Int; 2016 Oct; 36(10):1490-7. PubMed ID: 26936471
[TBL] [Abstract][Full Text] [Related]
15. The effect of radiotherapy in liver-confined but non-resectable Barcelona Clinic Liver Cancer stage C large hepatocellular carcinoma.
Yoon HI; Jung I; Han KH; Seong J
Oncotarget; 2016 Sep; 7(38):62715-62725. PubMed ID: 27486881
[TBL] [Abstract][Full Text] [Related]
16. Treatment patterns for hepatocellular carcinoma in patients with Child-Pugh class B and their impact on survival: A Korean nationwide registry study.
Jeon D; Song GW; Lee HC; Shim JH
Liver Int; 2022 Dec; 42(12):2830-2842. PubMed ID: 36287103
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008-2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centers.
Rodríguez de Lope C; Reig M; Matilla A; Ferrer MT; Dueñas E; Mínguez B; F Castroagudín J; Ortiz I; Pascual S; Lledó JL; Gallego A; Arenas JI; Aracil C; Forne M; Muñoz C; Pons F; Sala M; Iñarrairaegui M; Martin-Llahi M; Andreu V; Garre C; Rendón P; Fuentes J; Crespo J; Rodríguez M; Bruix J; Varela M;
Med Clin (Barc); 2017 Jul; 149(2):61-71. PubMed ID: 28279536
[TBL] [Abstract][Full Text] [Related]
18. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P
Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812
[TBL] [Abstract][Full Text] [Related]
19. Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis
.
Huang Y; Chen B; Liu N; Li N; Dao H; Chen W; Yang J
Int J Clin Pharmacol Ther; 2017 Jun; 55(6):498-508. PubMed ID: 28157070
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma in elderly: Clinical characteristics, treatments and outcomes compared with younger adults.
Guo H; Wu T; Lu Q; Dong J; Ren YF; Nan KJ; Lv Y; Zhang XF
PLoS One; 2017; 12(9):e0184160. PubMed ID: 28886106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
